Silverfin false false 31/03/2025 02/11/2023 31/03/2025 Dr D Masud 01/11/2023 Dr C Masud 01/11/2023 26 June 2025 no description of principal activity 15256181 2025-03-31 15256181 bus:Director1 2025-03-31 15256181 bus:Director2 2025-03-31 15256181 core:CurrentFinancialInstruments 2025-03-31 15256181 core:ShareCapital 2025-03-31 15256181 core:RetainedEarningsAccumulatedLosses 2025-03-31 15256181 core:ComputerEquipment 2023-11-01 15256181 2023-11-01 15256181 core:ComputerEquipment 2025-03-31 15256181 core:ImmediateParent core:CurrentFinancialInstruments 2025-03-31 15256181 core:ListedExchangeTraded core:WithinOneYear 2025-03-31 15256181 2023-11-02 2025-03-31 15256181 bus:FilletedAccounts 2023-11-02 2025-03-31 15256181 bus:SmallEntities 2023-11-02 2025-03-31 15256181 bus:AuditExemptWithAccountantsReport 2023-11-02 2025-03-31 15256181 bus:PrivateLimitedCompanyLtd 2023-11-02 2025-03-31 15256181 bus:Director1 2023-11-02 2025-03-31 15256181 bus:Director2 2023-11-02 2025-03-31 15256181 core:ComputerEquipment core:TopRangeValue 2023-11-02 2025-03-31 15256181 core:ComputerEquipment 2023-11-02 2025-03-31 15256181 core:CurrentFinancialInstruments 2023-11-02 2025-03-31 15256181 1 2023-11-02 2025-03-31 iso4217:GBP xbrli:pure

Company No: 15256181 (England and Wales)

ORCHARD MEDICAL & PSYCHIATRIC SERVICES LTD

Unaudited Financial Statements
For the financial period from 02 November 2023 to 31 March 2025
Pages for filing with the registrar

ORCHARD MEDICAL & PSYCHIATRIC SERVICES LTD

Unaudited Financial Statements

For the financial period from 02 November 2023 to 31 March 2025

Contents

ORCHARD MEDICAL & PSYCHIATRIC SERVICES LTD

STATEMENT OF FINANCIAL POSITION

As at 31 March 2025
ORCHARD MEDICAL & PSYCHIATRIC SERVICES LTD

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 March 2025
Note 31.03.2025
£
Fixed assets
Tangible assets 3 3,269
3,269
Current assets
Debtors 4 24,731
Investments 5 254
Cash at bank and in hand 74
25,059
Creditors: amounts falling due within one year 6 ( 20,718)
Net current assets 4,341
Total assets less current liabilities 7,610
Net assets 7,610
Capital and reserves
Called-up share capital 100
Profit and loss account 7,510
Total shareholder's funds 7,610

For the financial period ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Orchard Medical & Psychiatric Services Ltd (registered number: 15256181) were approved and authorised for issue by the Board of Directors. They were signed on its behalf by:

Dr D Masud
Director

26 June 2025

ORCHARD MEDICAL & PSYCHIATRIC SERVICES LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 02 November 2023 to 31 March 2025
ORCHARD MEDICAL & PSYCHIATRIC SERVICES LTD

NOTES TO THE FINANCIAL STATEMENTS

For the financial period from 02 November 2023 to 31 March 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial period, unless otherwise stated.

General information and basis of accounting

Orchard Medical & Psychiatric Services Ltd (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 8 The Courtyard Wyncolls Road, Severalls Industrial Park, Colchester, CO4 9PE, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Reporting period length

The company's first accounting period is from incorporation on 2 November 2023 to 31 March 2025.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where a contract has only been partially completed at the Statement of Financial Position date turnover represents the fair value of the service provided to date based on the stage of completion of the contract activity at the Statement of Financial Position date. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Computer equipment 5 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Income Statement as described below.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

Period from
02.11.2023 to
31.03.2025
Number
Monthly average number of persons employed by the Company during the period, including directors 2

3. Tangible assets

Computer equipment Total
£ £
Cost
At 02 November 2023 0 0
Additions 4,008 4,008
At 31 March 2025 4,008 4,008
Accumulated depreciation
At 02 November 2023 0 0
Charge for the financial period 739 739
At 31 March 2025 739 739
Net book value
At 31 March 2025 3,269 3,269

4. Debtors

31.03.2025
£
Trade debtors 19,450
Amounts owed by Parent undertakings 950
Prepayments 4,331
24,731

5. Current asset investments

31.03.2025
£
Listed investments – at fair value 254

6. Creditors: amounts falling due within one year

31.03.2025
£
Trade creditors 270
Amounts owed to directors 1,101
Accruals 2,160
Corporation tax 17,187
20,718

There are no amounts included above in respect of which any security has been given by the company.

7. Ultimate controlling party

The ultimate parent company is Orchard Family Holdings Ltd, a company incorporated in England and Wales.